Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 24, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 10 April 2025 - 15:22

Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Date of authorisation: 20/05/2016, Revision: 24, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/darzalex

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters